Neoadjuvant Intralesional Injection of Talimogene Laherparepvec

NCT06660810 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

2

Enrollment

OTHER

Sponsor class

Conditions

Soft Tissue Sarcoma
Sarcoma,Soft Tissue

Interventions

DRUG: Talimogene Laherparepvec
RADIATION: Neoadjuvant Radiation
PROCEDURE: Surgery

Sponsor

John Rieth

Collaborators

[object Object]